Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Calamos International Growth C CIGCX
- NAV / 1-Day Return 17.70 / 0.00
- Total Assets 243.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.950%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield —
- Turnover 131%
USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:07 PM GMT+0
Morningstar’s Analysis CIGCX
Will CIGCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 33.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 6.23 | 14.1 Mil | Healthcare |
ASML Holding NV | 3.87 | 8.7 Mil | Technology |
Advantest Corp | 3.70 | 8.4 Mil | Technology |
Rolls-Royce Holdings PLC | 3.48 | 7.8 Mil | Industrials |
Shopify Inc Registered Shs -A- Subord Vtg | 3.07 | 6.9 Mil | Technology |
Taiwan Semiconductor Manufacturing Co Ltd | 2.89 | 6.5 Mil | Technology |
Constellation Software Inc | 2.73 | 6.1 Mil | Technology |
Gerresheimer AG | 2.61 | 5.9 Mil | Healthcare |
MercadoLibre Inc | 2.59 | 5.8 Mil | Consumer Cyclical |
SAP SE | 2.58 | 5.8 Mil | Technology |